Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 147

    1.

    Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study.

    Naessén T, Persson I, Adami HO, Bergström R, Bergkvist L.

    Ann Intern Med. 1990 Jul 15;113(2):95-103.PMID: 2360759 [PubMed - indexed for MEDLINE]Related articles

    2.

    The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years.

    Larsson K, Ljunghall S, Krusemo UB, Naessén T, Lindh E, Persson I.

    J Intern Med. 1993 Dec;234(6):585-93.PMID: 8258750 [PubMed - indexed for MEDLINE]Related articles

    3.

    Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.

    Falkeborn M, Persson I, Terént A, Adami HO, Lithell H, Bergström R.

    Arch Intern Med. 1993 May 24;153(10):1201-9.PMID: 8388207 [PubMed - indexed for MEDLINE]Related articles

    4.

    Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group.

    Michaëlsson K, Baron JA, Farahmand BY, Johnell O, Magnusson C, Persson PG, Persson I, Ljunghall S.

    BMJ. 1998 Jun 20;316(7148):1858-63.PMID: 9632404 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.

    Persson I, Adami HO, Bergkvist L, Lindgren A, Pettersson B, Hoover R, Schairer C.

    BMJ. 1989 Jan 21;298(6667):147-51.PMID: 2538173 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement.

    Falkeborn M, Persson I, Adami HO, Bergström R, Eaker E, Lithell H, Mohsen R, Naessén T.

    Br J Obstet Gynaecol. 1992 Oct;99(10):821-8.PMID: 1419993 [PubMed - indexed for MEDLINE]Related articles

    7.

    Risk for fracture in women with low serum levels of thyroid-stimulating hormone.

    Bauer DC, Ettinger B, Nevitt MC, Stone KL; Study of Osteoporotic Fractures Research Group.

    Ann Intern Med. 2001 Apr 3;134(7):561-8.PMID: 12803168 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effect of hip fracture on mortality in elderly women: the EPIDOS prospective study.

    Empana JP, Dargent-Molina P, Bréart G; EPIDOS Group.

    J Am Geriatr Soc. 2004 May;52(5):685-90.PMID: 15086646 [PubMed - indexed for MEDLINE]Related articles

    9.

    Hip fractures in women with breast cancer.

    Adami HO, Zack M, Kressner U, Persson I, Berglund A, Naessén T, Bergkvist L.

    Am J Epidemiol. 1990 Nov;132(5):877-83.PMID: 2239902 [PubMed - indexed for MEDLINE]Related articles

    10.

    Reduced risk of hip fracture in women with endometrial cancer.

    Persson I, Naessén T, Adami HO, Bergström R, Lagrelius A, Möllerström G, Pettersson B, von Hamos K.

    Int J Epidemiol. 1992 Aug;21(4):636-42.PMID: 1521965 [PubMed - indexed for MEDLINE]Related articles

    11.

    Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish women.

    Grodstein F, Stampfer MJ, Falkeborn M, Naessen T, Persson I.

    Epidemiology. 1999 Sep;10(5):476-80.PMID: 10468418 [PubMed - indexed for MEDLINE]Related articles

    12.

    Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

    Kiel DP, Felson DT, Anderson JJ, Wilson PW, Moskowitz MA.

    N Engl J Med. 1987 Nov 5;317(19):1169-74.PMID: 3657888 [PubMed - indexed for MEDLINE]Related articles

    13.

    Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up.

    Mallmin H, Ljunghall S, Persson I, Naessén T, Krusemo UB, Bergström R.

    Calcif Tissue Int. 1993 Apr;52(4):269-72.PMID: 8467406 [PubMed - indexed for MEDLINE]Related articles

    14.

    Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group.

    Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR.

    Ann Intern Med. 1995 Jan 1;122(1):9-16.PMID: 7985914 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Forearm fractures as predictors of subsequent osteoporotic fractures.

    Cuddihy MT, Gabriel SE, Crowson CS, O'Fallon WM, Melton LJ 3rd.

    Osteoporos Int. 1999;9(6):469-75.PMID: 10624452 [PubMed - indexed for MEDLINE]Related articles

    16.

    Hip fracture prediction in elderly men and women: validation in the Rotterdam study.

    De Laet CE, Van Hout BA, Burger H, Weel AE, Hofman A, Pols HA.

    J Bone Miner Res. 1998 Oct;13(10):1587-93.PMID: 9783547 [PubMed - indexed for MEDLINE]Related articles

    17.

    Use of low potency estrogens does not reduce the risk of hip fracture.

    Michaëlsson K, Baron JA, Farahmand BY, Ljunghall S.

    Bone. 2002 Apr;30(4):613-8.PMID: 11934654 [PubMed - indexed for MEDLINE]Related articles

    18.

    Smoking eliminates the protective effect of oral estrogens on the risk for hip fracture among women.

    Kiel DP, Baron JA, Anderson JJ, Hannan MT, Felson DT.

    Ann Intern Med. 1992 May 1;116(9):716-21.PMID: 1558342 [PubMed - indexed for MEDLINE]Related articles

    19.

    Differences in risk factor patterns between cervical and trochanteric hip fractures. Swedish Hip Fracture Study Group.

    Michaëlsson K, Weiderpass E, Farahmand BY, Baron JA, Persson PG, Zidén L, Zetterberg C, Ljunghall S.

    Osteoporos Int. 1999;10(6):487-94.PMID: 10663350 [PubMed - indexed for MEDLINE]Related articles

    20.

    Variation in the efficacy of hormone replacement therapy in the prevention of hip fracture. Swedish Hip Fracture Study Group.

    Michaëlsson K, Baron JA, Johnell O, Persson I, Ljunghall S.

    Osteoporos Int. 1998;8(6):540-6.PMID: 10326058 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data